HighPoint Advisor Group LLC Decreases Stake in GE HealthCare Technologies Inc. $GEHC

HighPoint Advisor Group LLC cut its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 33.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 33,432 shares of the company’s stock after selling 16,670 shares during the period. HighPoint Advisor Group LLC’s holdings in GE HealthCare Technologies were worth $2,511,000 at the end of the most recent reporting period.

Other large investors also recently bought and sold shares of the company. Allianz SE raised its holdings in shares of GE HealthCare Technologies by 165.2% during the second quarter. Allianz SE now owns 350 shares of the company’s stock valued at $26,000 after purchasing an additional 218 shares during the last quarter. E Fund Management Hong Kong Co. Ltd. grew its position in GE HealthCare Technologies by 130.7% in the 3rd quarter. E Fund Management Hong Kong Co. Ltd. now owns 346 shares of the company’s stock worth $26,000 after purchasing an additional 196 shares during the period. Godsey & Gibb Inc. purchased a new stake in GE HealthCare Technologies during the 3rd quarter valued at $26,000. Oakworth Capital Inc. lifted its holdings in shares of GE HealthCare Technologies by 1,876.2% during the 3rd quarter. Oakworth Capital Inc. now owns 415 shares of the company’s stock valued at $31,000 after buying an additional 394 shares during the period. Finally, Gladwyn Financial Advisors Inc. purchased a new position in shares of GE HealthCare Technologies in the 2nd quarter worth $34,000. 82.06% of the stock is currently owned by institutional investors.

GE HealthCare Technologies Trading Down 0.4%

Shares of GEHC opened at $82.31 on Friday. The company has a debt-to-equity ratio of 0.91, a current ratio of 1.37 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a 1 year low of $57.65 and a 1 year high of $94.80. The company has a 50 day simple moving average of $82.72 and a two-hundred day simple moving average of $77.50. The firm has a market cap of $37.49 billion, a P/E ratio of 18.05, a price-to-earnings-growth ratio of 2.46 and a beta of 1.08.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its earnings results on Wednesday, February 4th. The company reported $1.44 earnings per share for the quarter, topping analysts’ consensus estimates of $1.40 by $0.04. The firm had revenue of $5.70 billion during the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a net margin of 10.11% and a return on equity of 21.35%. GE HealthCare Technologies’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, February 13th. Investors of record on Friday, January 9th will be paid a dividend of $0.035 per share. The ex-dividend date of this dividend is Friday, January 9th. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio is presently 2.89%.

Analyst Ratings Changes

A number of research analysts have weighed in on GEHC shares. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and increased their target price for the company from $73.00 to $77.00 in a report on Thursday, January 15th. BTIG Research increased their price objective on shares of GE HealthCare Technologies from $87.00 to $91.00 and gave the stock a “buy” rating in a research note on Wednesday. Citigroup raised their price objective on shares of GE HealthCare Technologies from $83.00 to $88.00 and gave the stock a “neutral” rating in a report on Thursday, December 11th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a report on Monday, December 29th. Finally, Evercore ISI increased their price target on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock an “outperform” rating in a research report on Thursday. Seven equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, GE HealthCare Technologies currently has an average rating of “Hold” and a consensus price target of $92.42.

Trending Headlines about GE HealthCare Technologies

Here are the key news stories impacting GE HealthCare Technologies this week:

• Positive Sentiment: Q4 results and outlook beat — GEHC reported $1.44 EPS (vs. $1.40 est.) and $5.7B revenue (vs. $5.6B est.), and raised FY‑2026 EPS guidance to $4.95–5.15 (above consensus), a key driver of recent optimism. GE HealthCare reports fourth quarter and full year 2025 financial results
• Positive Sentiment: Evercore ISI raised its price target to $98 with an “outperform” rating ( ~19% upside from current levels), signalling continued analyst confidence after the quarter. Benzinga
• Positive Sentiment: Wells Fargo boosted its PT to $97 and kept an “overweight” rating, citing the stronger results/guidance as support for higher estimates. Benzinga
• Positive Sentiment: BTIG raised its price target to $91 and maintained a “buy” call, another vote of confidence from the sell side after the quarter. GE HealthCare (GEHC) PT Raised to $91 at BTIG
• Neutral Sentiment: Market commentary is bullish on further upside — pieces noting the post‑earnings “pop” argue room remains to run, but they largely reflect sentiment rather than new fundamentals. GE HealthCare Technologies Pops, And The Upside Isn’t Over Yet
• Negative Sentiment: Margin pressure noted — several reports highlight a slide in net margin driven by tariffs and product mix, which tempers the EPS beat and could limit multiple expansion. GE HealthCare Q4 Earnings and Revenues Beat Estimates, Net Margin Falls
• Negative Sentiment: Coverage notes profit fell despite higher revenue — the WSJ and others emphasize the profitability hit, a reminder that growth is not yet fully translating into margin expansion. GE HealthCare Technologies Posts Lower Profit, Despite Higher Revenue

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.